Loading...
A 12-week prospective randomized controlled comparative trial of vilazodone and sertraline in Indian patients with depression
BACKGROUND: Depressive disorders are considered to be one of the leading causes of morbidity and mortality accounting for 4.3% of total disability-adjusted life years. Selective serotonin reuptake inhibitors and serotonin–norepinephrine reuptake inhibitors have greater efficacy and lesser side effec...
Na minha lista:
| Udgivet i: | Indian J Pharmacol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer - Medknow
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7074431/ https://ncbi.nlm.nih.gov/pubmed/32201441 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijp.IJP_618_18 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|